OTTAWA (Reuters) – Canada, under pressure over the slow pace of inoculations against COVID-19, has signed its first deal to allow a foreign vaccine to be manufactured domestically, Prime Minister Justin Trudeau said on Tuesday.
Trudeau told reporters that the Novavax Inc vaccine – still awaiting approval from Canadian regulators – would be produced in a new government facility in Montreal that is due to be finished later this year.
(Reporting by David Ljunggren and Steve Scherer)
